Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | SARS-CoV-2 | Methodology

A versatile web app for identifying the drivers of COVID-19 epidemics

Authors: Wayne M. Getz, Richard Salter, Ludovica Luisa Vissat, Nir Horvitz

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Background

No versatile web app exists that allows epidemiologists and managers around the world to comprehensively analyze the impacts of COVID-19 mitigation. The http://​covid-webapp.​numerusinc.​com/​ web app presented here fills this gap.

Methods

Our web app uses a model that explicitly identifies susceptible, contact, latent, asymptomatic, symptomatic and recovered classes of individuals, and a parallel set of response classes, subject to lower pathogen-contact rates. The user inputs a CSV file of incidence and, if of interest, mortality rate data. A default set of parameters is available that can be overwritten through input or online entry, and a user-selected subset of these can be fitted to the model using maximum-likelihood estimation (MLE). Model fitting and forecasting intervals are specifiable and changes to parameters allow counterfactual and forecasting scenarios. Confidence or credible intervals can be generated using stochastic simulations, based on MLE values, or on an inputted CSV file containing Markov chain Monte Carlo (MCMC) estimates of one or more parameters.

Results

We illustrate the use of our web app in extracting social distancing, social relaxation, surveillance or virulence switching functions (i.e., time varying drivers) from the incidence and mortality rates of COVID-19 epidemics in Israel, South Africa, and England. The Israeli outbreak exhibits four distinct phases: initial outbreak, social distancing, social relaxation, and a second wave mitigation phase. An MCMC projection of this latter phase suggests the Israeli epidemic will continue to produce into late November an average of around 1500 new case per day, unless the population practices social-relaxation measures at least 5-fold below the level in August, which itself is 4-fold below the level at the start of July. Our analysis of the relatively late South African outbreak that became the world’s fifth largest COVID-19 epidemic in July revealed that the decline through late July and early August was characterised by a social distancing driver operating at more than twice the per-capita applicable-disease-class (pc-adc) rate of the social relaxation driver. Our analysis of the relatively early English outbreak, identified a more than 2-fold improvement in surveillance over the course of the epidemic. It also identified a pc-adc social distancing rate in early August that, though nearly four times the pc-adc social relaxation rate, appeared to barely contain a second wave that would break out if social distancing was further relaxed.

Conclusion

Our web app provides policy makers and health officers who have no epidemiological modelling or computer coding expertise with an invaluable tool for assessing the impacts of different outbreak mitigation policies and measures. This includes an ability to generate an epidemic-suppression or curve-flattening index that measures the intensity with which behavioural responses suppress or flatten the epidemic curve in the region under consideration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, Wu Q, Merler S, Viboud C, Vespignani A, et al. Changes in contact patterns shape the dynamics of the covid-19 outbreak in china. Science. 2020. Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, Wu Q, Merler S, Viboud C, Vespignani A, et al. Changes in contact patterns shape the dynamics of the covid-19 outbreak in china. Science. 2020.
2.
go back to reference Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-ncov) outbreak. J Travel Med. 2020;27(2):020.CrossRef Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-ncov) outbreak. J Travel Med. 2020;27(2):020.CrossRef
3.
go back to reference Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, et al. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in shenzhen, china: a retrospective cohort study. The Lancet Infectious Diseases. 2020. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, et al. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in shenzhen, china: a retrospective cohort study. The Lancet Infectious Diseases. 2020.
4.
go back to reference Tang B, Xia F, Tang S, Bragazzi NL, Li Q, Sun X, Liang J, Xiao Y, Wu J. The effectiveness of quarantine and isolation determine the trend of the covid-19 epidemics in the final phase of the current outbreak in china. International Journal of Infectious Diseases. 2020. Tang B, Xia F, Tang S, Bragazzi NL, Li Q, Sun X, Liang J, Xiao Y, Wu J. The effectiveness of quarantine and isolation determine the trend of the covid-19 epidemics in the final phase of the current outbreak in china. International Journal of Infectious Diseases. 2020.
5.
go back to reference Park SW, Cornforth DM, Dushoff J, Weitz JS. The time scale of asymptomatic transmission affects estimates of epidemic potential in the covid-19 outbreak. Epidemics. 2020;100392. Park SW, Cornforth DM, Dushoff J, Weitz JS. The time scale of asymptomatic transmission affects estimates of epidemic potential in the covid-19 outbreak. Epidemics. 2020;100392.
6.
go back to reference Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerging infectious diseases. 2020;26(7). Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerging infectious diseases. 2020;26(7).
7.
go back to reference Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, Bhatia S, Boonyasiri A, Cucunuba Perez Z, Cuomo-Dannenburg G, et al. Report 9: Impact of non-pharmaceutical interventions (npis) to reduce covid19 mortality and healthcare demand. Technology and Medicine: Imperial College of Science; 2020. Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, Bhatia S, Boonyasiri A, Cucunuba Perez Z, Cuomo-Dannenburg G, et al. Report 9: Impact of non-pharmaceutical interventions (npis) to reduce covid19 mortality and healthcare demand. Technology and Medicine: Imperial College of Science; 2020.
8.
go back to reference Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (sars-cov-2). Science. 2020;368(6490):489–93.CrossRef Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (sars-cov-2). Science. 2020;368(6490):489–93.CrossRef
9.
go back to reference Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y, Kostelich E, Gumel AB To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the covid-19 pandemic. Infectious Disease Modelling. 2020. Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y, Kostelich E, Gumel AB To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the covid-19 pandemic. Infectious Disease Modelling. 2020.
10.
go back to reference Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: estimation and application. Annals Internal Med. 2020;172(9):577–82.CrossRef Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: estimation and application. Annals Internal Med. 2020;172(9):577–82.CrossRef
11.
go back to reference Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung S-M, Yuan B, Kinoshita R, Nishiura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(2):538.CrossRef Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung S-M, Yuan B, Kinoshita R, Nishiura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(2):538.CrossRef
12.
go back to reference Bar-On YM, Sender R, Flamholz AI, Phillips R, Milo R A quantitative compendium of covid-19 epidemiology. arXiv preprint arXiv:2006.01283 2020. Bar-On YM, Sender R, Flamholz AI, Phillips R, Milo R A quantitative compendium of covid-19 epidemiology. arXiv preprint arXiv:​2006.​01283 2020.
13.
go back to reference Hethcote HW The basic epidemiology models: models, expressions for r0, parameter estimation, and applications. In: Mathematical Understanding of Infectious Disease Dynamics, pp. 1–61. World Scientific, 2009. Hethcote HW The basic epidemiology models: models, expressions for r0, parameter estimation, and applications. In: Mathematical Understanding of Infectious Disease Dynamics, pp. 1–61. World Scientific, 2009.
14.
go back to reference Van den Driessche P, Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Mathematical Biosci. 2002;180(1):29–48.CrossRef Van den Driessche P, Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Mathematical Biosci. 2002;180(1):29–48.CrossRef
15.
go back to reference Sette A, Crotty S. Pre-existing immunity to sars-cov-2: the knowns and unknowns. Nature Reviews Immunology. 2020;1–2. Sette A, Crotty S. Pre-existing immunity to sars-cov-2: the knowns and unknowns. Nature Reviews Immunology. 2020;1–2.
16.
go back to reference Getz WM, Salter R, Muellerklein O, Yoon HS, Tallam K. Modeling epidemics: A primer and numerus model builder implementation. Epidemics. 2018;25:9–19.CrossRef Getz WM, Salter R, Muellerklein O, Yoon HS, Tallam K. Modeling epidemics: A primer and numerus model builder implementation. Epidemics. 2018;25:9–19.CrossRef
17.
go back to reference Hamra G, MacLehose R, Richardson D. Markov chain monte carlo: an introduction for epidemiologists. Int J Epidemiol. 2013;42(2):627–34.CrossRef Hamra G, MacLehose R, Richardson D. Markov chain monte carlo: an introduction for epidemiologists. Int J Epidemiol. 2013;42(2):627–34.CrossRef
18.
go back to reference Roberts GO, Rosenthal JS, et al. General state space markov chains and mcmc algorithms. Probability Surveys. 2004;1:20–71.CrossRef Roberts GO, Rosenthal JS, et al. General state space markov chains and mcmc algorithms. Probability Surveys. 2004;1:20–71.CrossRef
19.
go back to reference Ricon-Becker I, Tarrasch R, Blinder P, Ben-Eliyahu S A seven-day cycle in covid-19 infection and mortality rates: Are inter-generational social interactions on the weekends killing susceptible people? medRxiv 2020. Ricon-Becker I, Tarrasch R, Blinder P, Ben-Eliyahu S A seven-day cycle in covid-19 infection and mortality rates: Are inter-generational social interactions on the weekends killing susceptible people? medRxiv 2020.
20.
go back to reference Rossman H, Keshet A, Shilo S, Gavrieli A, Bauman T, Cohen O, Shelly E, Balicer R, Geiger B, Dor Y, et al. A framework for identifying regional outbreak and spread of covid-19 from one-minute population-wide surveys. Nature Med. 2020;26(5):634–8.CrossRef Rossman H, Keshet A, Shilo S, Gavrieli A, Bauman T, Cohen O, Shelly E, Balicer R, Geiger B, Dor Y, et al. A framework for identifying regional outbreak and spread of covid-19 from one-minute population-wide surveys. Nature Med. 2020;26(5):634–8.CrossRef
21.
go back to reference Last M The first wave of covid-19 in israel-initial analysis of publicly available data. medRxiv 2020. Last M The first wave of covid-19 in israel-initial analysis of publicly available data. medRxiv 2020.
22.
go back to reference Bodas M, Peleg K. Self-isolation compliance in the covid-19 era influenced by compensation: Findings from a recent survey in israel: Public attitudes toward the covid-19 outbreak and self-isolation: a cross sectional study of the adult population of israel. Health Affairs. 2020;39(6):936–41.CrossRef Bodas M, Peleg K. Self-isolation compliance in the covid-19 era influenced by compensation: Findings from a recent survey in israel: Public attitudes toward the covid-19 outbreak and self-isolation: a cross sectional study of the adult population of israel. Health Affairs. 2020;39(6):936–41.CrossRef
23.
go back to reference Yue M, Clapham HE, Cook AR. Estimating the size of a covid-19 epidemic from surveillance systems. Epidemiology. 2020;31(4):567–9.PubMedPubMedCentral Yue M, Clapham HE, Cook AR. Estimating the size of a covid-19 epidemic from surveillance systems. Epidemiology. 2020;31(4):567–9.PubMedPubMedCentral
24.
go back to reference Silverman JD, Hupert N, Washburne AD. Using influenza surveillance networks to estimate state-specific prevalence of sars-cov-2 in the united states. Science translational medicine. 2020;12(554). Silverman JD, Hupert N, Washburne AD. Using influenza surveillance networks to estimate state-specific prevalence of sars-cov-2 in the united states. Science translational medicine. 2020;12(554).
25.
go back to reference Yasaka TM, Lehrich BM, Sahyouni R. Peer-to-peer contact tracing: development of a privacy-preserving smartphone app. JMIR mHealth uHealth. 2020;8(4):18936.CrossRef Yasaka TM, Lehrich BM, Sahyouni R. Peer-to-peer contact tracing: development of a privacy-preserving smartphone app. JMIR mHealth uHealth. 2020;8(4):18936.CrossRef
26.
go back to reference Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui L-P, Johnston JC, Lan Z, Law S, MacLean E, Trajman A, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. bmj 2020;370. Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui L-P, Johnston JC, Lan Z, Law S, MacLean E, Trajman A, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. bmj 2020;370.
27.
go back to reference Huang R, Liu M, Ding Y. Spatial-temporal distribution of covid-19 in china and its prediction: A data-driven modeling analysis. J Infect Developing Countries. 2020;14(03):246–53.CrossRef Huang R, Liu M, Ding Y. Spatial-temporal distribution of covid-19 in china and its prediction: A data-driven modeling analysis. J Infect Developing Countries. 2020;14(03):246–53.CrossRef
28.
go back to reference Kramer AM, Pulliam JT, Alexander LW, Park AW, Rohani P, Drake JM. Spatial spread of the west africa ebola epidemic. Open Sci. 2016;3(8):160294. Kramer AM, Pulliam JT, Alexander LW, Park AW, Rohani P, Drake JM. Spatial spread of the west africa ebola epidemic. Open Sci. 2016;3(8):160294.
29.
go back to reference Getz WM, Salter R, Mgbara W. Adequacy of seir models when epidemics have spatial structure: Ebola in sierra leone. Philosophical Transactions of the Royal Society B. 2019;374(1775):20180282.CrossRef Getz WM, Salter R, Mgbara W. Adequacy of seir models when epidemics have spatial structure: Ebola in sierra leone. Philosophical Transactions of the Royal Society B. 2019;374(1775):20180282.CrossRef
30.
go back to reference Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Opensafely: factors associated with covid-19 death in 17 million patients. Nature. 2020;1–11. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Opensafely: factors associated with covid-19 death in 17 million patients. Nature. 2020;1–11.
31.
go back to reference Lakshmi Priyadarsini S, Suresh M. Factors influencing the epidemiological characteristics of pandemic covid 19: A tism approach. Int J Healthcare Management. 2020;13(2):89–98.CrossRef Lakshmi Priyadarsini S, Suresh M. Factors influencing the epidemiological characteristics of pandemic covid 19: A tism approach. Int J Healthcare Management. 2020;13(2):89–98.CrossRef
32.
go back to reference Saltelli A, Tarantola S, Campolongo F, Ratto M Sensitivity Analysis in Practice: a Guide to Assessing Scientific Models vol. 1. Wiley Online Library, 2004. Saltelli A, Tarantola S, Campolongo F, Ratto M Sensitivity Analysis in Practice: a Guide to Assessing Scientific Models vol. 1. Wiley Online Library, 2004.
33.
go back to reference Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355.CrossRef Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355.CrossRef
34.
go back to reference Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y, Mills MC. Demographic science aids in understanding the spread and fatality rates of covid-19. Proceedings of the National Academy of Sciences. 2020;117(18):9696–8.CrossRef Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y, Mills MC. Demographic science aids in understanding the spread and fatality rates of covid-19. Proceedings of the National Academy of Sciences. 2020;117(18):9696–8.CrossRef
35.
go back to reference Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, Mytton O, Bonell C, Booy R School closure and management practices during coronavirus outbreaks including covid-19: a rapid systematic review. The Lancet Child & Adolescent Health 2020. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, Mytton O, Bonell C, Booy R School closure and management practices during coronavirus outbreaks including covid-19: a rapid systematic review. The Lancet Child & Adolescent Health 2020.
36.
go back to reference Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, y Piontti AP, Mu K, Rossi L, Sun K, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (covid-19) outbreak. Science. 2020;368(6489):395–400.CrossRef Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, y Piontti AP, Mu K, Rossi L, Sun K, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (covid-19) outbreak. Science. 2020;368(6489):395–400.CrossRef
37.
go back to reference Getz WM, Marshall CR, Carlson CJ, Giuggioli L, Ryan SJ, Romañach SS, Boettiger C, Chamberlain SD, Larsen L, D’Odorico P, et al. Making ecological models adequate. Ecology letters. 2018;21(2):153–66.CrossRef Getz WM, Marshall CR, Carlson CJ, Giuggioli L, Ryan SJ, Romañach SS, Boettiger C, Chamberlain SD, Larsen L, D’Odorico P, et al. Making ecological models adequate. Ecology letters. 2018;21(2):153–66.CrossRef
38.
go back to reference Heesterbeek JAP. A brief history of r 0 and a recipe for its calculation. Acta Biotheoretica. 2002;50(3):189–204.CrossRef Heesterbeek JAP. A brief history of r 0 and a recipe for its calculation. Acta Biotheoretica. 2002;50(3):189–204.CrossRef
39.
go back to reference Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, de Larrea NF, et al. Prevalence of sars-cov-2 in spain (ene-covid): a nationwide, population-based seroepidemiological study. The Lancet. 2020. Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, de Larrea NF, et al. Prevalence of sars-cov-2 in spain (ene-covid): a nationwide, population-based seroepidemiological study. The Lancet. 2020.
40.
go back to reference Larsen LG, Eppinga MB, Passalacqua P, Getz WM, Rose KA, Liang M. Appropriate complexity landscape modeling. Earth Sci Rev. 2016;160:111–30.CrossRef Larsen LG, Eppinga MB, Passalacqua P, Getz WM, Rose KA, Liang M. Appropriate complexity landscape modeling. Earth Sci Rev. 2016;160:111–30.CrossRef
41.
go back to reference Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The socio-economic implications of the coronavirus and covid-19 pandemic: a review. International Journal of Surgery. 2020. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The socio-economic implications of the coronavirus and covid-19 pandemic: a review. International Journal of Surgery. 2020.
42.
go back to reference Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3.CrossRef Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3.CrossRef
43.
go back to reference Evans TS, Shi Z, Boots M, Liu W, Olival KJ, Xiao X, Vandewoude S, Brown H, Chen J-L, Civitello DJ, et al. Synergistic china-us ecological research is essential for global emerging infectious disease preparedness. EcoHealth. 2020;1–14. Evans TS, Shi Z, Boots M, Liu W, Olival KJ, Xiao X, Vandewoude S, Brown H, Chen J-L, Civitello DJ, et al. Synergistic china-us ecological research is essential for global emerging infectious disease preparedness. EcoHealth. 2020;1–14.
44.
go back to reference Reperant LA, Osterhaus AD Aids, avian flu, sars, mers, ebola, zik... what next? Vaccine 35. 2017;(35), 4470–4474. Reperant LA, Osterhaus AD Aids, avian flu, sars, mers, ebola, zik... what next? Vaccine 35. 2017;(35), 4470–4474.
45.
go back to reference Tian H, Liu Y, Li Y, Wu C-H, Chen B, Kraemer MU, Li B, Cai J, Xu B, Yang Q, et al. An investigation of transmission control measures during the first 50 days of the covid-19 epidemic in china. Science. 2020;368(6491):638–42.CrossRef Tian H, Liu Y, Li Y, Wu C-H, Chen B, Kraemer MU, Li B, Cai J, Xu B, Yang Q, et al. An investigation of transmission control measures during the first 50 days of the covid-19 epidemic in china. Science. 2020;368(6491):638–42.CrossRef
46.
go back to reference McKinley TJ, Ross JV, Deardon R, Cook AR. Simulation-based bayesian inference for epidemic models. Computational Statistics Data Analysis. 2014;71:434–47.CrossRef McKinley TJ, Ross JV, Deardon R, Cook AR. Simulation-based bayesian inference for epidemic models. Computational Statistics Data Analysis. 2014;71:434–47.CrossRef
47.
go back to reference Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, Priesemann V. Inferring change points in the spread of covid-19 reveals the effectiveness of interventions. Science. 2020. Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, Priesemann V. Inferring change points in the spread of covid-19 reveals the effectiveness of interventions. Science. 2020.
48.
go back to reference Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of sars-cov-2 through the postpandemic period. Science. 2020;368(6493):860–8.CrossRef Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of sars-cov-2 through the postpandemic period. Science. 2020;368(6493):860–8.CrossRef
Metadata
Title
A versatile web app for identifying the drivers of COVID-19 epidemics
Authors
Wayne M. Getz
Richard Salter
Ludovica Luisa Vissat
Nir Horvitz
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-02736-2

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.